🧬 ARA-290 (Cibinetide) – Research Peptide
🧬 Product Overview
ARA-290, also known as Cibinetide, is a synthetic peptide derived from erythropoietin (EPO) but specifically engineered to target the innate repair receptor (IRR) without stimulating erythropoiesis. This selective mechanism has made ARA-290 a key compound in research focused on tissue protection, cellular repair, and inflammatory pathway modulation.
Unlike full-length EPO, ARA-290 is designed to retain cytoprotective signaling while minimizing effects on red blood cell production, making it highly relevant in advanced studies of regenerative biology and cellular stress response.
🔬 Key Research Applications
- Studies on innate repair receptor (IRR) activation
- Research into tissue protection and cellular repair mechanisms
- Investigation of inflammatory pathway modulation
- Exploration of neurological signaling and nerve-related pathways
- Cellular studies related to oxidative stress and recovery processes
ARA-290 is frequently used in experimental models examining how targeted receptor activation can support cellular resilience and repair without affecting hematopoietic pathways.
⚗️ Product Specifications
- Purity: ≥ 99% (HPLC tested)
- Form: Lyophilized peptide powder
- Appearance: White/off-white powder
- Quantity: [e.g., 2mg / 5mg]
- Storage: Store in a cool, dry environment (2–8°C recommended)
🧪 Reconstitution & Handling
ARA-290 should be reconstituted using bacteriostatic water or appropriate laboratory-grade solvents under sterile conditions. Proper handling and storage protocols must be followed to maintain peptide stability and effectiveness.
🚚 Packaging & Quality Assurance
Each vial of ARA-290 is:
- Manufactured under strict quality control standards
- Tested for purity, identity, and consistency
- Securely sealed and packaged to ensure safe delivery
⚠️ Important Disclaimer
This product is intended for research purposes only.
Not for human consumption, therapeutic, or diagnostic use.

Reviews
There are no reviews yet.